IBO · Impact Biomedical Inc. · Documents
$4.85
+0.01 (+0.21%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As reflected in the accompanying financial statements the Company has incurred operating losses as well as negative cash flows from operating activities over the past two years. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued.”View the 10-Q filed Aug 7, 2026
Market Cap
$48.61M
Shares
8.54M
Volume · Oct 5
17.34K
Avg daily vol (9 sessions)
16.07K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-09-17 | 2026-09-16 | |
| 8-K | 2026-09-15 | 2026-09-14 | |
| 10-Q | 2026-08-07 | 2026-06-30 | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 10-K | 2026-03-11 | 2025-12-31 | |
| 8-K | 2026-03-04 | 2026-02-27 | |
| 10-Q | 2025-11-07 | 2025-09-30 | |
| 8-K | 2025-11-06 | 2025-11-05 | |
| 8-K | 2025-10-27 | 2025-10-24 | |
| DEF 14A | 2025-09-22 | — | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-07-28 | 2025-07-21 | |
| 8-K | 2025-06-23 | — | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| 8-K | 2025-04-03 | — | |
| 8-K | 2025-03-28 | 2025-03-24 | |
| 10-K | 2025-03-28 | 2024-12-31 | |
| 8-K | 2025-03-13 | 2025-03-11 | |
| 8-K | 2025-01-29 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-04 | — | |
| 8-K | 2024-10-08 | 2024-10-03 | |
| 8-K | 2024-09-17 | 2024-09-16 | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-06-07 | 2024-06-06 | |
| 10-Q | 2024-05-10 | 2024-03-31 | |
| 10-K | 2024-02-20 | 2023-12-31 | |
| 8-K | 2024-01-22 | 2024-01-18 | |
| 10-Q | 2023-11-13 | 2023-09-30 | |
| 8-K | 2023-11-06 | 2023-10-31 | |
| 10-Q | 2023-10-05 | 2023-06-30 |
Showing 1–31 of 31 filings